Cargando…

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer

BACKGROUND: Cancer associated fibroblasts (CAFs) are key stroma cells that play dominant roles in tumor progression. However, the CAFs-derived molecular determinants that regulate colorectal cancer (CRC) metastasis and chemoresistance have not been fully characterized. METHODS: CAFs and NFs were obt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, J. L., Wang, W., Lan, X. L., Zeng, Z. C., Liang, Y. S., Yan, Y. R., Song, F. Y., Wang, F. F., Zhu, X. H., Liao, W. J., Liao, W. T., Ding, Y. Q., Liang, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503554/ https://www.ncbi.nlm.nih.gov/pubmed/31064356 http://dx.doi.org/10.1186/s12943-019-1019-x

Ejemplares similares

Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial–mesenchymal transition in human hepatocellular carcinoma
por: Jia, R-J, et al.
Publicado: (2014)

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
por: Zhang, X, et al.
Publicado: (2017)

DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis
por: Zhao, F, et al.
Publicado: (2015)

IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer
por: Zhu, S, et al.
Publicado: (2015)

Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
por: Shi, Z-M, et al.
Publicado: (2017)

EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition
por: Sun, M, et al.
Publicado: (2014)

Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis
por: Xu, Q, et al.
Publicado: (2016)

Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer
por: Fan, X-J, et al.
Publicado: (2012)

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
por: Chen, X, et al.
Publicado: (2013)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
por: Chen, Y-L, et al.
Publicado: (2013)

SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer
por: Zhao, X, et al.
Publicado: (2014)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

Suppression of epithelial–mesenchymal transition and apoptotic pathways by miR-294/302 family synergistically blocks let-7-induced silencing of self-renewal in embryonic stem cells
por: Guo, W-T, et al.
Publicado: (2015)

FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer
por: Yang, S S, et al.
Publicado: (2017)

Exosome and epithelial–mesenchymal transition: A complex secret of cancer progression
por: Dhar, Rajib, et al.
Publicado: (2023)

Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial–mesenchymal transition-induced angiogenesis
por: Li, C, et al.
Publicado: (2016)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

Knockdown of BAG3 induces epithelial–mesenchymal transition in thyroid cancer cells through ZEB1 activation
por: Meng, X, et al.
Publicado: (2014)

Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
por: Zhang, X, et al.
Publicado: (2016)

miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial–mesenchymal transition
por: Wang, B, et al.
Publicado: (2014)

Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D
por: Onallah, Hadil, et al.
Publicado: (2022)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Effects of early post-hatch feeding on the growth performance, hormone secretion, intestinal morphology, and intestinal microbiota structure in broilers
por: Li, D.L., et al.
Publicado: (2022)

Integrated analyses identify the involvement of microRNA-26a in epithelial–mesenchymal transition during idiopathic pulmonary fibrosis
por: Liang, H, et al.
Publicado: (2014)

The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer
por: He, G Y, et al.
Publicado: (2016)

LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
por: Hou, P, et al.
Publicado: (2014)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
por: Liang, S-Q, et al.
Publicado: (2015)

Lung cancer exosomes as drivers of epithelial mesenchymal transition
por: Rahman, Mohammad A., et al.
Publicado: (2016)

Detection of the mesenchymal-to-epithelial transition of invasive non-small cell lung cancer cells by their membrane undulation spectra
por: Hui, T. H., et al.
Publicado: (2020)

Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure
por: Wang, Y., et al.
Publicado: (2014)

miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells
por: Chen, Y, et al.
Publicado: (2013)

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
por: Xie, G, et al.
Publicado: (2014)

Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
por: Tang, X, et al.
Publicado: (2016)

Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities
por: Lin, L Y, et al.
Publicado: (2016)

Revisiting epithelial‐mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
por: Liao, Tsai‐Tsen, et al.
Publicado: (2017)

Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma
por: Zeng, A-L, et al.
Publicado: (2017)

Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance
por: Hu, Y.-B., et al.
Publicado: (2018)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial–mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling
por: Xu, X, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gcsfk7igb3hge703ln9ip0uooh